NIRAVI
LIVE

Serial Number

90004908

Owner

Sparsha Pharma USA, Inc.

Attorney

Gary Brenner

First Use Date

Aug 11, 2020

Filing Date

Jun 16, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NIRAVI Trademark

Serial Number: 90004908 • Registration: 6302871

NIRAVI is a trademark filed by Sparsha Pharma USA, Inc. on June 16, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Sparsha Pharma USA, Inc. (2 trademarks)

3919 Oceanic Drive
Oceanside, CA 92056

Entity Type: 03

Trademark Details

Filing Date

June 16, 2020

Registration Date

March 23, 2021

First Use Anywhere

August 11, 2020

First Use in Commerce

August 11, 2020

Published for Opposition

October 27, 2020

Goods & Services

Transdermal patches featuring lidocaine

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 23, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 23, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 16, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 15, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 26, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 25, 2021 AITU
USE AMENDMENT FILED
Jan 5, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 5, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 22, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 27, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 27, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 7, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2020 CNSA
ASSIGNED TO EXAMINER
Sep 17, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2020 NWOS
NEW APPLICATION ENTERED
Jun 19, 2020 NWAP